JP Morgan Maintains Overweight on IDEAYA Biosciences, Lowers Price Target to $55

Benzinga · 1d ago
JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from $62 to $55.